Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Food Funct ; 15(13): 7093-7107, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38873879

ABSTRACT

Heat stress can impair the male reproductive function. L-Theanine and dihydromyricetin have biological activities against heat stress; however, their effects on reproductive function in heat-stressed males are unclear. In this study, male mice were given L-theanine, dihydromyricetin, or a combination of both for 28 days, followed by 2 h of heat stress daily for 7 days. All interventions alleviated heat stress-induced testicular damage, improving the testicular organ index, sperm density, acrosome integrity, sperm deformity rate, and hormone levels. Treatment increased the antioxidant enzyme activity and decreased the markers of oxidative and inflammatory stress in the testes. A combination dose of 200 + 200 mg kg-1 d-1 showed the best protective effect. The potential mechanism involves the regulation of HSP27 and HSP70, which regulate the levels of reproductive hormones through the StAR/Cyp11a1/Hsd3b1/Cyp17a1/Hsd17b3 pathway, alleviate inflammation and oxidative stress through the P38/NF-κB/Nrf2/HO-1 pathway, and regulate the Bcl-2/Fas/Caspase3 apoptotic pathway. Overall, L-theanine and dihydromyricetin may play a protective role against heat stress-induced reproductive dysfunction, suggesting their potential use in heat stress-resistant foods.


Subject(s)
Flavonols , Glutamates , Oxidative Stress , Testis , Animals , Male , Flavonols/pharmacology , Mice , Testis/drug effects , Testis/metabolism , Glutamates/pharmacology , Oxidative Stress/drug effects , Heat-Shock Response/drug effects , Spermatozoa/drug effects , Reproduction/drug effects , Antioxidants/pharmacology , Protective Agents/pharmacology , HSP70 Heat-Shock Proteins/metabolism , Apoptosis/drug effects
2.
Int J Nanomedicine ; 19: 3773-3804, 2024.
Article in English | MEDLINE | ID: mdl-38708181

ABSTRACT

Geriatric diseases are a group of diseases with unique characteristics related to senility. With the rising trend of global aging, senile diseases now mainly include endocrine, cardiovascular, neurodegenerative, skeletal, and muscular diseases and cancer. Compared with younger populations, the structure and function of various cells, tissues and organs in the body of the elderly undergo a decline as they age, rendering them more susceptible to external factors and diseases, leading to serious tissue damage. Tissue damage presents a significant obstacle to the overall health and well-being of older adults, exerting a profound impact on their quality of life. Moreover, this phenomenon places an immense burden on families, society, and the healthcare system.In recent years, stem cell-derived exosomes have become a hot topic in tissue repair research. The combination of these exosomes with biomaterials allows for the preservation of their biological activity, leading to a significant improvement in their therapeutic efficacy. Among the numerous biomaterial options available, hydrogels stand out as promising candidates for loading exosomes, owing to their exceptional properties. Due to the lack of a comprehensive review on the subject matter, this review comprehensively summarizes the application and progress of combining stem cell-derived exosomes and hydrogels in promoting tissue damage repair in geriatric diseases. In addition, the challenges encountered in the field and potential prospects are presented for future advancements.


Subject(s)
Exosomes , Hydrogels , Stem Cells , Exosomes/chemistry , Humans , Hydrogels/chemistry , Aged , Aging/physiology , Animals , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacology , Geriatrics
3.
Front Immunol ; 14: 1294317, 2023.
Article in English | MEDLINE | ID: mdl-38111578

ABSTRACT

Diabetic nephropathy (DN) is a chronic inflammatory disease that affects millions of diabetic patients worldwide. The key to treating of DN is early diagnosis and prevention. Once the patient enters the clinical proteinuria stage, renal damage is difficult to reverse. Therefore, developing early treatment methods is critical. DN pathogenesis results from various factors, among which the immune response and inflammation play major roles. Ferroptosis is a newly discovered type of programmed cell death characterized by iron-dependent lipid peroxidation and excessive ROS production. Recent studies have demonstrated that inflammation activation is closely related to the occurrence and development of ferroptosis. Moreover, hyperglycemia induces iron overload, lipid peroxidation, oxidative stress, inflammation, and renal fibrosis, all of which are related to DN pathogenesis, indicating that ferroptosis plays a key role in the development of DN. Therefore, this review focuses on the regulatory mechanisms of ferroptosis, and the mutual regulatory processes involved in the occurrence and development of DN and inflammation. By discussing and analyzing the relationship between ferroptosis and inflammation in the occurrence and development of DN, we can deepen our understanding of DN pathogenesis and develop new therapeutics targeting ferroptosis or inflammation-related regulatory mechanisms for patients with DN.


Subject(s)
Diabetes Mellitus , Diabetic Nephropathies , Ferroptosis , Humans , Diabetic Nephropathies/pathology , Oxidative Stress , Kidney/pathology , Inflammation/metabolism , Diabetes Mellitus/metabolism
4.
Biomed Pharmacother ; 168: 115818, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37939612

ABSTRACT

Diabetic nephropathy (DN) is a prevalent chronic microvascular complication associated with diabetes mellitus and represents a major cause of chronic kidney disease and renal failure. Current treatment strategies for DN primarily focus on symptom alleviation, lacking effective approaches to halt or reverse DN progression. Circular RNA (circRNA), characterized by a closed-loop structure, has emerged as a novel non-coding RNA regulator of gene expression, attributed to its conservation, stability, specificity, and multifunctionality. Dysregulation of circRNA expression is closely associated with DN progression, whereby circRNA impacts kidney cell injury by modulating cell cycle, differentiation, cell death, as well as influencing the release of inflammatory factors and stromal fibronectin expression. Consequently, circRNA is considered a predictive biomarker and a potential therapeutic target for DN. This review provides an overview of the latest research progress in the classification, functions, monitoring methods, and databases related to circRNA. The paper focuses on elucidating the impact and underlying mechanisms of circRNA on kidney cells under diabetic conditions, aiming to offer novel insights into the prevention, diagnosis, and treatment of DN.


Subject(s)
Diabetes Mellitus , Diabetic Nephropathies , Humans , Diabetic Nephropathies/diagnosis , Diabetic Nephropathies/genetics , Diabetic Nephropathies/therapy , RNA, Circular/genetics , RNA, Circular/metabolism , Kidney/metabolism , Biomarkers/metabolism , Diabetes Mellitus/metabolism
5.
Front Immunol ; 14: 1274654, 2023.
Article in English | MEDLINE | ID: mdl-37954576

ABSTRACT

Diabetes mellitus is a metabolic disease that is characterized by chronic hyperglycemia due to a variety of etiological factors. Long-term metabolic stress induces harmful inflammation leading to chronic complications, mainly diabetic ophthalmopathy, diabetic cardiovascular complications and diabetic nephropathy. With diabetes complications being one of the leading causes of disability and death, the use of anti-inflammatories in combination therapy for diabetes is increasing. There has been increasing interest in targeting significant regulators of the inflammatory pathway, notably receptor-interacting serine/threonine-kinase-1 (RIPK1) and receptor-interacting serine/threonine-kinase-3 (RIPK3), as drug targets for managing inflammation in treating diabetes complications. In this review, we aim to provide an up-to-date summary of current research on the mechanism of action and drug development of RIPK1 and RIPK3, which are pivotal in chronic inflammation and immunity, in relation to diabetic complications which may be benefit for explicating the potential of selective RIPK1 and RIPK3 inhibitors as anti-inflammatory therapeutic agents for diabetic complications.


Subject(s)
Diabetes Complications , Diabetes Mellitus , Diabetic Nephropathies , Humans , Inflammation/drug therapy , Inflammation/metabolism , Diabetes Complications/drug therapy , Receptor-Interacting Protein Serine-Threonine Kinases/metabolism , Threonine , Serine , Diabetes Mellitus/drug therapy , Diabetes Mellitus/etiology
6.
Mol Med ; 29(1): 135, 2023 Oct 12.
Article in English | MEDLINE | ID: mdl-37828444

ABSTRACT

Diabetic kidney disease (DKD) is the main cause of end-stage renal disease, and its clinical manifestations are progressive proteinuria, decreased glomerular filtration rate, and renal failure. The injury and death of glomerular podocytes are the keys to DKD. Currently, a variety of cell death modes have been identified in podocytes, including apoptosis, autophagy, endoplasmic reticulum (ER) stress, pyroptosis, necroptosis, ferroptosis, mitotic catastrophe, etc. The signaling pathways leading to these cell death processes are interconnected and can be activated simultaneously or in parallel. They are essential for cell survival and death that determine the fate of cells. With the deepening of the research on the mechanism of cell death, more and more researchers have devoted their attention to the underlying pathologic research and the drug therapy research of DKD. In this paper, we discussed the podocyte physiologic role and DKD processes. We also provide an overview of the types and specific mechanisms involved in each type of cell death in DKD, as well as related targeted therapy methods and drugs are reviewed. In the last part we discuss the complexity and potential crosstalk between various modes of cell death, which will help improve the understanding of podocyte death and lay a foundation for new and ideal targeted therapy strategies for DKD treatment in the future.


Subject(s)
Diabetes Mellitus , Diabetic Nephropathies , Podocytes , Humans , Diabetic Nephropathies/pathology , Podocytes/metabolism , Podocytes/pathology , Cell Death , Apoptosis , Epithelial Cells/metabolism , Diabetes Mellitus/metabolism
7.
Front Endocrinol (Lausanne) ; 14: 1215292, 2023.
Article in English | MEDLINE | ID: mdl-37600716

ABSTRACT

Diabetic nephropathy (DN) and diabetic retinopathy (DR) are the most serious and common diabetes-associated complications. DN and DR are all highly prevalent and dangerous global diseases, but the underlying mechanism remains to be elucidated. Ferroptosis, a relatively recently described type of cell death, has been confirmed to be involved in the occurrence and development of various diabetic complications. The disturbance of cellular iron metabolism directly triggers ferroptosis, and abnormal iron metabolism is closely related to diabetes. However, the molecular mechanism underlying the role of ferroptosis in DN and DR is still unclear, and needs further study. In this review article, we summarize and evaluate the mechanism of ferroptosis and its role and progress in DN and DR, it provides new ideas for the diagnosis and treatment of DN and DR.


Subject(s)
Diabetes Mellitus , Diabetic Nephropathies , Diabetic Retinopathy , Ferroptosis , Retinal Diseases , Humans , Diabetic Nephropathies/etiology , Diabetic Retinopathy/etiology , Iron
8.
Front Cardiovasc Med ; 10: 1135723, 2023.
Article in English | MEDLINE | ID: mdl-36970345

ABSTRACT

Diabetes is a common chronic metabolic disease, and its incidence continues to increase year after year. Diabetic patients mainly die from various complications, with the most common being diabetic cardiomyopathy. However, the detection rate of diabetic cardiomyopathy is low in clinical practice, and targeted treatment is lacking. Recently, a large number of studies have confirmed that myocardial cell death in diabetic cardiomyopathy involves pyroptosis, apoptosis, necrosis, ferroptosis, necroptosis, cuproptosis, cellular burial, and other processes. Most importantly, numerous animal studies have shown that the onset and progression of diabetic cardiomyopathy can be mitigated by inhibiting these regulatory cell death processes, such as by utilizing inhibitors, chelators, or genetic manipulation. Therefore, we review the role of ferroptosis, necroptosis, and cuproptosis, three novel forms of cell death in diabetic cardiomyopathy, searching for possible targets, and analyzing the corresponding therapeutic approaches to these targets.

9.
Nanotechnology ; 34(1)2022 Oct 17.
Article in English | MEDLINE | ID: mdl-36174390

ABSTRACT

Interfacial properties of van der Waals (vdW) heterostructures dominate the durability and function of their booming practical and potential applications such as opoelectronic devices, superconductors and even pandemics research. However, the strain engineering modulates of interlayer friction of vdW heterostructures consisting of two distinct materials are still unclear, which hinders the applications of vdW heterostructures, as well as the design of solid lubricant and robust superlubricity. In the present paper, a molecular model between a hexagonal graphene flake and a rectangular SLMoS2sheet is established, and the influence of biaxial and uniaxial strain on interlayer friction is explored by molecular dynamics. It is found that the interlayer friction is insensitive to applied strains. Strong robustness of superlubricity between distinct layers is owed to the structure's intrinsic incommensurate characteristics and the existence of Moiré pattern. In engineering practice, it is of potential importance to introduce two distinct 2D materials at the sliding contact interface to reduce the interfacial friction of the contact pair and serve as ideal solid lubricants. Our research provides a further basis to explore the nanotribology and strain engineering of 2D materials and vdW heterostructures.

10.
Int J Biol Macromol ; 209(Pt A): 1516-1525, 2022 Jun 01.
Article in English | MEDLINE | ID: mdl-35452701

ABSTRACT

Elevated expressions of transforming growth factor ß1 (TGF-ß1) have been implicated in the pathogenesis of liver fibrosis, thus attenuating the excessive TGF-ß1's activity by TGF-ß1-binding peptide is an ideal strategy for the treatment of liver fibrosis. However, the application of small peptide as a pharmaceutical agent is obstacle due to difficult preparation and non-selective delivery. The I-plus sequences of circumsporozoite protein (CSP-I) possesses high affinity for heparan sulfate proteoglycans, which are primarily located on liver tissues. TGF-ß1-binding peptide P15 holds specific ability of binding to TGF-ß1. In this study, we describe an approach to efficiently preparing liver-targeting peptide P15-CSP-I, which is conjugation of the sequences of P15 to the N-terminus of CSP-I, from the cleavage of biological macromolecule SUMO-tagged P15-CSP-I. In vitro and ex vivo binding assay showed that P15-CSP-I specifically targeted to the hepatocytes and liver tissues. Moreover, P15-CSP-I inhibited cell proliferation, migration and invasion, and decreased fibrosis-related proteins expression in TGF-ß1-activated HSCs in vitro. Furthermore, P15-CSP-I ameliorated liver morphology and decreased the fibrosis responses in vivo. Taken together, P15-CSP-I may be a potential candidate for targeting therapy on liver fibrosis due to its high efficient preparation, specific liver-targeting potential and improved anti-liver fibrotic activity.


Subject(s)
Heparan Sulfate Proteoglycans , Liver , Transforming Growth Factor beta1 , Animals , Heparan Sulfate Proteoglycans/metabolism , Humans , Liver/metabolism , Liver Cirrhosis/pathology , Mice , Peptides/metabolism , Rats , SUMO-1 Protein/metabolism , Transforming Growth Factor beta1/metabolism
11.
Phys Chem Chem Phys ; 21(35): 19115-19125, 2019 Sep 21.
Article in English | MEDLINE | ID: mdl-31432807

ABSTRACT

In this paper, the wrinkling and failure behavior of single layer MoS2 (SLMoS2) sheets under in-plane shear is investigated using molecular simulations and the nonlocal model. Wrinkling and failure features, such as the stress-strain relation, the amplitude and the half-wavelength, are comprehensively explored. The effects of size, temperature and pre-existing cracks on the wrinkling and failure behavior are then taken into consideration. It is found that the whole process can be divided into three stages, i.e., the pre-buckling stage, the buckling stage and the failure stage. The classical continuum model is found to be limited in quantitatively analyzing the wrinkling behavior due to the lack of size effect. The nonlocal parameter, a key parameter to characterize the size effect, is first reported. What is more, compared with edge cracks, SLMoS2 sheets are more sensitive to pre-existing centre cracks. This work can provide a better understanding of the wrinkling and failure properties of SLMoS2 sheets under shear loads, and should be helpful for developing various flexible electronic devices.

SELECTION OF CITATIONS
SEARCH DETAIL
...